349 related articles for article (PubMed ID: 31446024)
1. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview.
Zhao J; Yang J; Xie Y
Int J Pharm; 2019 Oct; 570():118642. PubMed ID: 31446024
[TBL] [Abstract][Full Text] [Related]
2. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
3. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.
Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y
Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394
[TBL] [Abstract][Full Text] [Related]
4. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L.
Xie Y; Luo H; Duan J; Hong C; Ma P; Li G; Zhang T; Wu T; Ji G
Fitoterapia; 2014 Mar; 93():216-25. PubMed ID: 24462958
[TBL] [Abstract][Full Text] [Related]
5. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
6. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
7. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
[TBL] [Abstract][Full Text] [Related]
9. Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis.
Wang H; Xiao Y; Wang H; Sang Z; Han X; Ren S; Du R; Shi X; Xie Y
Int J Pharm; 2019 Jul; 566():67-76. PubMed ID: 31125715
[TBL] [Abstract][Full Text] [Related]
10. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
Rocha B; de Morais LA; Viana MC; Carneiro G
Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
[TBL] [Abstract][Full Text] [Related]
11. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
[TBL] [Abstract][Full Text] [Related]
12. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation.
Yao Y; Xie Y; Hong C; Li G; Shen H; Ji G
Carbohydr Polym; 2014 Sep; 110():329-37. PubMed ID: 24906763
[TBL] [Abstract][Full Text] [Related]
13. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
Karwal R; Garg T; Rath G; Markandeywar TS
Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
[TBL] [Abstract][Full Text] [Related]
14. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
15. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids.
Leonarduzzi G; Testa G; Sottero B; Gamba P; Poli G
Curr Med Chem; 2010; 17(1):74-95. PubMed ID: 19941477
[TBL] [Abstract][Full Text] [Related]
16. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X
Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Glucans Enhance Solubility of Bioavailable Flavonoids.
Park S
Molecules; 2016 Nov; 21(11):. PubMed ID: 27854350
[TBL] [Abstract][Full Text] [Related]
18. QbD based development of proliposome of lopinavir for improved oral bioavailability.
Patel GM; Shelat PK; Lalwani AN
Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
[TBL] [Abstract][Full Text] [Related]
19. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation.
Qian J; Meng H; Xin L; Xia M; Shen H; Li G; Xie Y
Colloids Surf B Biointerfaces; 2017 Dec; 160():101-109. PubMed ID: 28917148
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
